![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/07/16/2913567/0/en/Clearmind-Medicine-Announces-Submission-of-US-Patent-Application-for-Treating-Metabolic-Syndrome-and-Weight-loss.html
https://www.prnewswire.com/news-releases/advanced-orthomolecular-research-launches-pea-endocannabinoid-support-to-combat-chronic-inflammation-and-provide-the-benefits-of-cbd-without-the-stigma-300963234.html
https://www.prnewswire.com/news-releases/therapix-biosciences-announces-positive-topline-results-from-phase-iia-clinical-trial-of-thx-110-for-obstructive-sleep-apnea-program-300957479.html
https://www.prnewswire.com/news-releases/therapix-biosciences-announces-enrollment-of-the-first-patient-for-clinical-trial-at-assuta-medical-center-for-treating-obstructive-sleep-apnea-using-cannabinoid-based-drug-300660370.html